Chinese english Germany Japanese Korea

1-([4-(ACETYLAMINO)PHENYL]SULFONYL)PIPERIDINE-2-CARBOXYLIC ACID

1-([4-(ACETYLAMINO)PHENYL]SULFONYL)PIPERIDINE-2-CARBOXYLIC ACID Struktur
474625-95-1
CAS-Nr.
474625-95-1
Englisch Name:
1-([4-(ACETYLAMINO)PHENYL]SULFONYL)PIPERIDINE-2-CARBOXYLIC ACID
Synonyma:
AKOS BBS-00001510;IFLAB-BB F0774-0019;1-((4-acetamidophenyl)sulfonyl)piperidine-2-carboxylic acid;1-([4-(ACETYLAMINO)PHENYL]SULFONYL)PIPERIDINE-2-CARBOXYLIC ACID;2-Piperidinecarboxylic acid, 1-[[4-(acetylamino)phenyl]sulfonyl]-
CBNumber:
CB1151194
Summenformel:
C14H18N2O5S
Molgewicht:
326.37
MOL-Datei:
Mol file
Request For Quotation

1-([4-(ACETYLAMINO)PHENYL]SULFONYL)PIPERIDINE-2-CARBOXYLIC ACID Eigenschaften

Dichte
1.418±0.06 g/cm3(Predicted)
pka
3.38±0.20(Predicted)

Sicherheit

1-([4-(ACETYLAMINO)PHENYL]SULFONYL)PIPERIDINE-2-CARBOXYLIC ACID Chemische Eigenschaften,Einsatz,Produktion Methoden

1-([4-(ACETYLAMINO)PHENYL]SULFONYL)PIPERIDINE-2-CARBOXYLIC ACID Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

1-([4-(ACETYLAMINO)PHENYL]SULFONYL)PIPERIDINE-2-CARBOXYLIC ACID Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 7)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Matrix Scientific --
 sales@matrixscientific.com United States 6655 80
Ryan Scientific, Inc. --
 ryan.reichlyn@ryansci.com United States 6446 60
UkrOrgSynthesis Ltd. --
 y.barysheva@ukrorgsynth.com Ukraine 6234 38
Enamine --
 enamine@enamine.net Ukraine 6216 67
LIFE CHEMICALS, formerly I.F. Lab --
 vasily.pinchuk@lifechemicals.com Canada 6706 69
Zerenex Molecular Limited --
 sales@zerenex-molecular.com United Kingdom 6205 47
AKos Consulting & Solutions GmbH --
 akos@akosgmbh.de Germany 6723 72
  • IFLAB-BB F0774-0019
  • AKOS BBS-00001510
  • 1-([4-(ACETYLAMINO)PHENYL]SULFONYL)PIPERIDINE-2-CARBOXYLIC ACID
  • 1-((4-acetamidophenyl)sulfonyl)piperidine-2-carboxylic acid
  • 2-Piperidinecarboxylic acid, 1-[[4-(acetylamino)phenyl]sulfonyl]-
  • 474625-95-1
Copyright 2019 © ChemicalBook. All rights reserved